World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
43749
World Ranking
1228
National Ranking
79

Medicine

D-Index
87
Citations
43889
World Ranking
13406
National Ranking
715

Overview

Joachim R. Kalden was affiliated with the University of Erlangen-Nuremberg in Germany. The research primarily focused on the field of Medicine with a specialization in Rheumatology.

The scientist's work covered several subfields including:

  • Rheumatology
  • History
  • Dermatology
  • Clinical Psychology
  • Hematology

Key topics addressed in the research included:

  • Medical History and Research
  • Medicine and Dermatology Studies History
  • Historical Psychiatry and Medical Practices
  • Autoimmune and Inflammatory Disorders Research
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research

Joachim R. Kalden published papers in journals such as:

  • Aktuelle Rheumatologie
  • Zeitschrift für Rheumatologie

Notable publications include:

  • Zur Entwicklung der klinischen Rheumatologie in der Bundesrepublik Deutschland nach dem 2. Weltkrieg, 2021, Aktuelle Rheumatologie
  • 80 Meilensteine der Rheumatologie aus 80 Jahren - III: 1980-2000, 2021, Zeitschrift für Rheumatologie

Frequent co-authors associated with the scientist's work were:

  • Gerd-Rüdiger Burmester
  • Thomas Rose

Best Publications

  • Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

    R Maini;E W St Clair;F Breedveld;D Furst

  • Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

    Lars Klareskog;Désirée van der Heijde;Julien P de Jager;Andrew Gough

  • Immunosuppressive effects of apoptotic cells

    Reinhard E. Voll;Martin Herrmann;Edith A. Roth;Christian Stach

  • Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

    M J Elliott;R N Maini;M Feldmann;J R Kalden

  • Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

    Ravinder N. Maini;Ferdinand C. Breedveld;Joachim R. Kalden;Josef S. Smolen

  • Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

    Claudio Vitali;Stefano Bombardieri;Haralampos M. Moutsopoulos;Genesio Balestrieri

  • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

    E William St Clair;Désirée M F M van der Heijde;Josef S Smolen;Ravinder N Maini

  • Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

    Josef S Smolen;Joachim R Kalden;David L Scott;Blaz Rozman

  • Range of antinuclear antibodies in "healthy" individuals

    E. M. Tan;T. E. W. Feltkamp;J. S. Smolen;B. Butcher

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • IMPAIRED PHAGOCYTOSIS OF APOPTOTIC CELL MATERIAL BY MONOCYTE-DERIVED MACROPHAGES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

    Martin Herrmann;Reinhard E. Voll;Otmar M. Zoller;Manuela Hagenhofer

  • A rapid and simple method for the isolation of apoptotic DNA fragments

    M Herrmann;H M Lorenz;R Voll;M Grünke

  • Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

    Christian E. Antoni;Arthur Kavanaugh;Bruce Kirkham;Zuhre Tutuncu

  • Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

    Peter Charles;Michael J. Elliott;Diana Davis;Alison Potter

  • The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.

    Kirsten Neubert;Silke Meister;Katrin Moser;Florian Weisel

  • Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.

    Irith Baumann;Wasilis Kolowos;Reinhard E. Voll;Bernhard Manger

  • Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE

    Vilma Urbonaviciute;Barbara G. Fürnrohr;Silke Meister;Luis Munoz

  • Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial

    Josef S. Smolen;Désirée M. F. M. Van Der Heijde;E. William St.Clair;Paul Emery

  • Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II.

    Martin A. Kriegel;Tobias Lohmann;Christoph Gabler;Norbert Blank

  • Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

    A Calin;B A C Dijkmans;P Emery;M Hakala

Frequent Co-Authors

Martin Herrmann
Martin Herrmann University of Erlangen-Nuremberg
Reinhard E. Voll
Reinhard E. Voll University of Freiburg
Udo S. Gaipl
Udo S. Gaipl University of Erlangen-Nuremberg
Bernhard Fleckenstein
Bernhard Fleckenstein University of Erlangen-Nuremberg
Paul Emery
Paul Emery University of Leeds
Thomas H. Winkler
Thomas H. Winkler University of Erlangen-Nuremberg
Gerd R. Burmester
Gerd R. Burmester Charité - University Medicine Berlin
Ferdinand C. Breedveld
Ferdinand C. Breedveld Leiden University Medical Center
Ravinder N. Maini
Ravinder N. Maini Imperial College London
Josef S. Smolen
Josef S. Smolen Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career in immunology, pursuing related online degrees such as nursing practitioner programs can be a strategic move. Many students seek the cheapest psych np programs online to gain specialized skills without a heavy financial burden. These programs provide flexibility, allowing professionals to balance work and study effectively.

Once certified, salaries for advanced practice roles vary by location. Understanding how much do dnps make can help guide career decisions and negotiate fair compensation. This insight is particularly valuable for professionals seeking long-term stability in healthcare.

Transitioning between specialties is common in nursing careers. For example, nurses looking to focus on intensive care can explore pathways such as the acute care nurse practitioner certification, which enables them to handle more critical patient needs and broaden their expertise.

Additionally, accelerated options like the accelerated np program offer a faster route to certification, ideal for motivated individuals aiming to enter the workforce quickly. These programs are designed to meet the growing demand for qualified nurse practitioners in specialized fields related to immunology and healthcare.

Best Scientists Citing Joachim R. Kalden

Recently Published Articles